Macleods' HCQ use for staff raises questions
Posted by
www.biotecnika.org
Drug marker Macleods Pharmaceuticals has decided to put its staff on
prophylaxis treatment of hydroxychlroquine (HCQ), even as a debate
rages over its efficacy in treating Covid-19 and whether it should be
given to non-health workers.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/macleods-hcq-use-for-staff-raises-questions/articleshow/76167574.cms
Subscribe to:
Post Comments (Atom)
Post a Comment